Thursday, October 29, 2009

52% of all Parenchymal Brain Tumor cases are Glioblastoma Multiforme

TX MedCenter @HybridMedical Business Intelligence Algorithm & Decision Theory shows Temozolomide & Radiation for Glioblastoma Multiforme Extends Life.

Glioblastoma multiforme, the most common and most aggressive form of brain cancer in adults, Glioblastoma is considered incurable. 52% of all parenchymal brain tumor cases are Glioblastoma multiforme.
If you are Diagnosed with Glioblastoma your choice is to have Radiation treatments or have Radiation with Adding Temozolomide. Oncology & Hybrid Medical Research shows after two years, 26.5 percent of patients in the radiation-plus-temozolomide were alive, compared with 10.4 percent of those who received radiation only. Temodar is the Generic for Temozolomide

Hybrid Medical
Research are Leaders in the following areas:

  • Breast cancer
  • Endocrine system cancer
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Gynaecological cancer
  • Haematological cancer
  • Head and neck cancer
  • Neurooncology
  • Paediatric oncology
  • Thoracic oncology
  • Sarcoma
  • Skin cancer
  • Epidemiology, cancer prevention, and cancer control
  • Supportive care
  • Imaging
  • Health-care systems

No comments:

Post a Comment